Live feed
Filing
SC 13G
SC 13G0001104659-22-022118·Checkmate Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Checkmate Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 162818108
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,333,254
- Percent of class
- 6.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-022118
- Form type
- SC 13G
- Filer
- Checkmate Pharmaceuticals, Inc.
- CIK
- CIK 1651431
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership